UnknownNot Applicable

Sarcopenia and Outcomes of Neuroplasty in Lumbar Spinal Stenosis

South Korea79 participantsStarted 2020-05-20

Plain-language summary

The aim of the present study is to find out the influence of sarcopenia on outcomes of neuroplasty in patients with lumbar spinal stenosis.

Who can participate

Age range65 Years – 79 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Presence of lumbar spinal stenosis on MRI * 65 ≤ age \<79 * Neurogenic claudication due to spinal stenosis * Chronic pain above than 3 months despite conservative therapies * Scheduled for neuroplasty with Racz catheter Exclusion Criteria: * Allergy to local anesthetics, contrast dye, or steroid * Use of anticoagulants or antiplatelet medication * Coagulopathy or Infection at the insertion site * Neurological or psychiatric disorders * Hemodynamic instability due to other underlying disorders * Prior spine instrumentation * Vascular claudication * Refusal to participate in the study

What they're measuring

Change in numeric rating scale (NRS) at 3 months after the procedure

Timeframe: Before the procedure and 3 months after the procedure

Change in Oswestry disability index (ODI) at 3 months after the procedure

Timeframe: Before the procedure and 3 months after the procedure

Global percieved effect (GPE) score at 3 months after the procedure

Timeframe: 3 months after the procedure

Change in Medication Quantification scale (MQS) at 3 months after the procedure

Timeframe: Before the procedure and 3 months after the procedure

The percentage of successful responders at 3 months after the procedure

Timeframe: 3 months after the procedure

Trial details

NCT IDNCT04374669

SponsorAsan Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-04-30

View on ClinicalTrials.gov More Lumbar Spinal Stenosis trials